| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 270,465 | 269,041 | 257,652 | 283,276 | | Cost of Revenue | 184,323 | 182,276 | 181,176 | 192,358 | | | Gross Profit | 86,142 | 86,765 | 76,476 | 90,918 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 61,588 | 61,917 | 57,154 | 60,701 | | Non Recurring |
-
|
-
|
-
| 267,849 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 24,554 | 24,848 | 19,322 | (237,632) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 15 | 50 | 65 | 299 | | Earnings Before Interest And Taxes | 24,569 | 24,898 | 19,387 | (237,333) | | Interest Expense | 5,775 | 5,773 | 5,774 | 6,330 | | Income Before Tax | 18,794 | 19,125 | 13,613 | (243,663) | | Income Tax Expense | 6,863 | 7,768 | 5,772 | (80,725) | | Minority Interest | (140) |
-
|
-
| (124) | | | | Net Income From Continuing Ops | 11,858 | 11,348 | 7,858 | (163,117) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (104) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,718 | 11,348 | 7,858 | (163,221) | | Preferred Stock And Other Adjustments | 5 | (56) | 51 |
-
| | | Net Income Applicable To Common Shares | $11,723 | $11,292 | $7,909 | ($163,221) |
|
0.51% Nasdaq 
Income Statement
